In 1998, I was diagnosed with metastatic melanoma and given months to live. I consulted more than a dozen leading oncologists and got conflicting recommendations. No one could tell me: ‘Which treatment is best for me?’

A clinical trial saved my life—despite itself being unsuccessful—only raising more questions. Why did this therapy work for me but not for others? Could my experience help similar patients? It was life-saving knowledge I wanted to share with all cancer patients.

Welcome to Cancer Commons.

Since our founding in 2011, we have delivered personalized, evidence-based guidance at no charge to more than 10,000 patients and caregivers, supported entirely by philanthropy.

Cancer Commons is staffed by accomplished researchers with PhDs in the molecular biology and pharmacology of cancer and in Artificial Intelligence. They have joined the Commons to apply their knowledge and expertise to help patients research their options in real time using the latest tools of precision oncology.

News & Events

  • Curious Dr. George Logo and Cancer Commons Logo with photo of Cancer Commons Director of Technology Michael Kramer with his late son, Theo.
    NEW Curious Dr. George—Raising AI Right: Prioritizing Humanity in Precision Medicine

    Here’s the latest from our Curious Dr. George! Read “Raising AI Right: Prioritizing Humanity in Precision Medicine” here. Artificial intelligence (AI) holds promise to transform cancer research and treatment. Here, Curious Dr. George asks our very own Director of Technology, Michael Kramer, about the powerful role Cancer Commons can play in shaping the future of AI in oncology. Having lost his son, Theo, to… Read more »

  • Curious Dr. George logo, Cancer Commons logo, photo of DeLeys Brandman, MD, Medical Director, Cancer Commons
    Curious Dr. George—Cancer Commons: Breaking Barriers in Cancer Care

    Here’s the latest from our Curious Dr. George! Read “Cancer Commons: Breaking Barriers in Cancer Care” here. For more than a decade, Cancer Commons has helped patients and their care teams access the information and data they need to make informed decisions. Demand for this kind of help is only growing. Here, Curious Dr. George asks our very own Medical Director, DeLeys Brandman, MD,… Read more »

  • Curious Dr. George logo, Cancer Commons logo, and photo of Jerald P. Radich, MD, MA, MS, Professor, Translational Science & Therapeutics Division, Kurt Enslein Endowed Chair, Fred Hutchinson Cancer Center
    Curious Dr. George—How an Expert Would Manage His Own Chronic Myelogenous Leukemia

    Here’s the latest from our Curious Dr. George! Read “How Would an Expert Manage His Own Chronic Myelogenous Leukemia?” here. When facing a frightening new cancer diagnosis, some people ask their doctors, “What would you do if you were me?” Here, our Curious Dr. George asks expert oncologist Jerald P. Radich MD, MA, MS, how he would handle his own hypothetical case of chronic… Read more »

  • They go above and beyond to help! They take the time to get to know you personally and are genuinely interested in your health and well being. Very kind, compassionate, and intelligent group of people!! I would highly recommend them!!

    Celeste
    Daughter of brain cancer patient

  • Whenever we needed them they were there. Whenever we needed new information or help finding a new treatment they were there immediately. They were such a pleasure to deal with that they were like a family member helping you out, and believe me I/we needed them. 

    Dr. Mel Burchman
    Spouse of a pancreatic cancer patient
  • When you’re completely overwhelmed by a glioblastoma diagnosis, it is quite miraculous to find Cancer Commons. Having a second opinion and someone to answer questions when we weren’t able to understand our doctor was very comforting. My husband’s tumor is currently stable, but we know where to turn if things change. Thank you!!

    Chris Bird
    Wife of a cancer patient

  • Words cannot describe enough the help, guidance, services, and advice I received from Cancer Commons—whether from online resources, the constant support provided by the dedicated scientist Dr. Matt Warner, or the selfless recommendations from a tumour board, so that at least I know what other experts are thinking and where treatment could be headed potentially, and plan course of action accordingly.

    Viji
    Wife of a glioblastoma patient

  • The group was useful, but Cancer Commons definitely sets itself apart. To have validation from experts who truly cared and spent time with me talking through all the options was just amazing. I didn’t feel rushed, and the review of my dad’s case was so thorough. Matt met us where we were at.

    Megan Anz